- The following slides provide an analysis of the type of data presented in the abstracts presented at AACR 2022 and relevant to the Beacon Adoptive Cell trial or drug pages.
- A total of 108 adoptive cell relevant abstracts which can be linked to therapy or trial have been identified from the meeting and we have taken the time to present a summary of these in this post-conference report.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements